4 months ago
SAGE
AnalystsSalveen RichterSalveen Richter's Stock Forecasts
AnalystsSalveen Richter
Analyst Ranking
Top 27%
#1188 out of 4414 analysts
Average Return
+1.61%
Win Rate
40%25 out of 62
Risk vs Reward
Poor
Good
Salveen Richter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | +569.03% | $23.51 | $157.29 | 2020-09-17 - 2021-09-17 | Strong Buy |
Passage Bio IncPASG | +150.07% | $14.02 | $35.06 | 2020-03-23 - 2020-06-25 | Strong Buy |
Denali Therapeutics IncDNLI | +149.21% | $27.98 | $69.73 | 2020-01-26 - 2021-01-27 | Strong Buy |
Moderna IncMRNA | +99.41% | $80.00 | $159.53 | 2020-05-17 - 2021-05-18 | Strong Buy |
Acorda Therapeutics IncACOR | +89.11% | $1,939.20 | $211.20 | 2018-12-10 - 2019-12-11 | Strong Sell |
Salveen Richter Analyst Color
Get additional color on Salveen Richter's coverage of popular stocks
a year ago
ALLO
Salveen Richter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 4 | Hold | $65.00 | +23.34% | Maintains | 7 days ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $136.00 | +342.28% | Maintains | 19 days ago |
Apellis Pharmaceuticals IncAPLS | 1 | Strong Buy | $74.00 | +56.91% | Initiates Coverage On | 20 days ago |
Uniqure NvQURE | 3 | Strong Buy | $63.00 | +802.58% | Maintains | 21 days ago |
Moderna IncMRNA | 5 | Strong Buy | $231.00 | +195.47% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Sell | $28.00 | -42.08% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 3 | Hold | $28.00 | +26.13% | Maintains | a month ago |
Sage Therapeutics IncSAGE | 4 | Hold | $25.00 | +29.74% | Maintains | 2 months ago |
2seventy Bio IncTSVT | 4 | Hold | $5.00 | +165.96% | Downgrades | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $5.00 | -16.67% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $215.00 | +160.26% | Maintains | 5 months ago |
Amicus Therapeutics IncFOLD | 1 | Hold | $11.00 | +3.97% | Maintains | 9 months ago |
Allogene Therapeutics IncALLO | 4 | Strong Buy | $31.00 | +1,101.55% | Maintains | 9 months ago |
Autodesk IncADSK | 1 | Strong Buy | $225.00 | +8.50% | Maintains | 9 months ago |
4d Molecular Therapeutics IncFDMT | 2 | Strong Buy | $68.00 | N/A | Upgrades | a year ago |
Prime Medicine IncPRME | 1 | Hold | $22.00 | N/A | Initiates Coverage On | a year ago |
Lyell Immunopharma IncLYEL | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Precision Biosciences IncDTIL | 3 | Hold | $1.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 2 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Recursion Pharmaceuticals IncRXRX | 3 | Hold | $9.00 | N/A | Maintains | a year ago |
Taysha Gene Therapies IncTSHA | 2 | Hold | $3.00 | N/A | Downgrades | a year ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Hold | $55.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 6 | Strong Sell | $12.00 | N/A | Downgrades | a year ago |
Sana Biotechnology IncSANA | 2 | Hold | $6.00 | N/A | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $442.00 | N/A | Maintains | a year ago |
Bread Financial Holdings IncBFH | 1 | Hold | $43.00 | N/A | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $270.00 | N/A | Maintains | a year ago |
Biogen IncBIIB | 2 | Strong Buy | $370.00 | N/A | Upgrades | a year ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $970.00 | N/A | Maintains | a year ago |
Bluebird Bio IncBLUE | 3 | Strong Sell | $3.00 | N/A | Maintains | a year ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $46.00 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 1 | Strong Sell | $4.00 | N/A | Maintains | 2 years ago |
Arcus Biosciences IncRCUS | 2 | Hold | $28.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $39.00 | N/A | Downgrades | 2 years ago |
Amgen IncAMGN | 1 | Strong Buy | $258.00 | N/A | Initiates Coverage On | 2 years ago |
Gilead Sciences IncGILD | 2 | Hold | $80.00 | N/A | Initiates Coverage On | 2 years ago |
Omega Therapeutics IncOMGA | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $10.00 | N/A | Downgrades | 2 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Passage Bio IncPASG | 3 | Strong Buy | $30.00 | N/A | Upgrades | 3 years ago |
Adaptive Biotechnologies CorpADPT | 1 | Hold | $63.00 | N/A | Downgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $151.00 | N/A | Initiates Coverage On | 4 years ago |
Paccar IncPCAR | 3 | Hold | $50.00 | N/A | Maintains | 4 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Cellectis SaCLLS | 1 | Strong Sell | $11.00 | N/A | Downgrades | 4 years ago |
Seagen IncSGEN | 1 | Strong Buy | $165.00 | N/A | Maintains | 4 years ago |
Denali Therapeutics IncDNLI | 2 | Strong Buy | $37.00 | N/A | Upgrades | 4 years ago |
Acorda Therapeutics IncACOR | 4 | Strong Sell | $1,200.00 | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Spark Therapeutics IncONCE | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.